Long-term real-world results of ibrutinib therapy in patients with relapsed or refractory chronic lymphocytic leukemia: 30-month follow up of the Swedish compassionate use cohort.
- DOI
- 10.3324/haematol.2018.198820
- Published
- 2019 May
- Container
- Haematologica
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.3324/haematol.2018.198820,
title = {Long-term real-world results of ibrutinib therapy in patients with relapsed or refractory chronic lymphocytic leukemia: 30-month follow up of the Swedish compassionate use cohort.},
author = {Winqvist M and Andersson PO and Asklid A and Karlsson K and Karlsson C and Lauri B and Lundin J and Mattsson M and Norin S and Sandstedt A and Rosenquist R and Späth F and Hansson L and Österborg A and Swedish CLL Group},
year = {2019},
journal = {Haematologica},
doi = {10.3324/haematol.2018.198820},
url = {https://doi.org/10.3324/haematol.2018.198820}
}RIS
TY - JOUR TI - Long-term real-world results of ibrutinib therapy in patients with relapsed or refractory chronic lymphocytic leukemia: 30-month follow up of the Swedish compassionate use cohort. AU - Winqvist M AU - Andersson PO AU - Asklid A AU - Karlsson K AU - Karlsson C AU - Lauri B AU - Lundin J AU - Mattsson M AU - Norin S AU - Sandstedt A AU - Rosenquist R AU - Späth F AU - Hansson L AU - Österborg A AU - Swedish CLL Group PY - 2019 JO - Haematologica DO - 10.3324/haematol.2018.198820 UR - https://doi.org/10.3324/haematol.2018.198820 ER -
APA
M, W., PO, A., A, A., K, K., C, K., B, L., J, L., M, M., S, N., A, S., R, R., F, S., L, H., A, Ö., & Group, S. C. (2019). Long-term real-world results of ibrutinib therapy in patients with relapsed or refractory chronic lymphocytic leukemia: 30-month follow up of the Swedish compassionate use cohort.. Haematologica. https://doi.org/10.3324/haematol.2018.198820
Source records
- pubmed · retrieved 2026-09-26T02:09:59.150Z